about
Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleepDirectional connectivity between frontal and posterior brain regions is altered with increasing concentrations of propofol[Palliative laser treatment of malignant lung tumors]Heart rate variability in healthy volunteers during normobaric and hyperbaric hyperoxia.Renal effects of dexmedetomidine during coronary artery bypass surgery: a randomized placebo-controlled study.Prolonged central mu-opioid receptor occupancy after single and repeated nalmefene dosing.Effect of the novel anxiolytic drug deramciclane on cytochrome P(450) 2D6 activity as measured by desipramine pharmacokinetics.Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial.Harnessing anesthesia and brain imaging for the study of human consciousness.Intravenous ethanol increases dopamine release in the ventral striatum in humans: PET study using bolus-plus-infusion administration of [(11)C]raclopride.Hormonal effects of MPV-2213ad, a new selective aromatase inhibitor, in healthy male subjects. A phase I studyStriatal dopamine D2 receptors in modulation of pain in humans: a review.Analysis of rapid heart rate variability in the assessment of anticholinergic drug effects in humans.Measurement of anticholinergic effects of psychotropic drugs in humans.The role of heart rate variability in risk stratification for adverse postoperative cardiac events.Validation of [(11) C]ORM-13070 as a PET tracer for alpha2c -adrenoceptors in the human brain.Imaging of α2C-adrenoceptors in the living brain: a method to monitor noradrenaline release?White matter damage of the brain is associated with poor outcome in vascular surgery patients with claudication: a pilot study.Wide inter-individual variability of bispectral index and spectral entropy at loss of consciousness during increasing concentrations of dexmedetomidine, propofol, and sevoflurane.Bioavailability of dexmedetomidine after extravascular doses in healthy subjects.The influence of drug input rate on the development of tolerance to frusemide.Analysis of heart rate variability dynamics during propofol and dexmedetomidine anesthesia.Kalman smoother based time-varying spectrum estimation of EEG during single agent propofol anesthesia.The effects of amitriptyline, citalopram and reboxetine on autonomic nervous system. A randomised placebo-controlled study on healthy volunteers.[Challenges and concerns in early-phase clinical trials]Pharmacokinetic-pharmacodynamic model for the anticholinergic effect of glycopyrrolate.The concentration-effect relationship of the respiratory depressant effects of alfentanil and fentanyl.Spontaneous baroreflex sensitivity as a dynamic measure of cardiac anticholinergic drug effect.Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity.Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man.Effects of surgical levels of propofol and sevoflurane anesthesia on cerebral blood flow in healthy subjects studied with positron emission tomography.Dopamine D2 receptor binding in the human brain is associated with the response to painful stimulation and pain modulatory capacity.Ketamine does not decrease striatal dopamine D2 receptor binding in man.Striatal dopamine D1 and D2 receptors in burning mouth syndrome.Striatal μ-opioid receptor availability predicts cold pressor pain threshold in healthy human subjects.Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects.Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans.Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.Altered dopamine D2 receptor binding in atypical facial pain.Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia.
P50
Q28257447-F7474E68-632B-4CCF-8B9E-3C74D98E8143Q28545146-01CCCAF4-0374-4A39-8B0B-97022AF0DB34Q30990195-B0A714F6-2EF3-4958-B589-45D1AED92FB4Q33421167-685178D9-66E9-4F1D-936D-5F4C952C84AAQ33909308-AA9EC6C2-9CF6-4975-B18A-DA2DEB8B7279Q33987817-5AC17A17-3A7E-46FB-97C4-69AEC3C52AE1Q34290781-1F27D768-03DB-463E-9B50-8DD4B9CFEF48Q34518237-3BD16991-7889-49A4-8E83-99F2C53CBFB5Q34985058-FB080942-76BA-48F8-A7DC-FE174650BCA8Q35143469-B7D924A9-4024-4913-B3A6-BBB90E2FE5A5Q35802104-49160296-66E7-426B-8AD2-927DFC25F157Q35908534-B41A8D7A-1E25-4549-8587-3814449D1757Q36245419-8F67A3FA-CE36-46B4-82AD-C363CCC8AE45Q36270493-9F7A7FAB-1971-4A14-8C45-88E67A272660Q37016547-9123D9E8-9B5B-42D2-A35F-657EF055675AQ39069924-2D6BEF23-6789-4C01-A28C-2B3E01D2D0B6Q39169172-02A6D0E2-EC53-4745-B006-0139E9F96830Q41645201-44932ACE-96C5-4A4B-A952-67EFC5240CA2Q42608047-AC0DA810-6761-4277-BDA8-4279F32B2CB1Q42760132-5D03D046-A554-4A85-81FA-22A628710792Q42781437-CDE4469F-0507-4A65-8F42-E14272A215DFQ42795094-562C5012-997B-4C89-AEC2-1A62BA942C46Q43229013-0398A3D6-79CD-4786-926C-5A1A1F3D868FQ43604998-B629EF2C-AC05-4282-B696-B8D9D2E08FB4Q43625901-2B002192-530F-4054-9974-E42E2ABDF379Q43647201-31EB7416-5FF6-46A0-A00E-7F49DC878614Q43748870-98F090EB-8F06-4B6E-AAFE-B750BF1D0EF1Q43778482-71366106-1AA0-48F9-8C84-2A5A0FD69DEFQ43949954-386E9735-A39D-429F-909F-D17652A42209Q44060471-F522BF38-2707-4B6E-85EA-B927827BA063Q44096116-218A2A61-8684-4C34-96AE-EFF0979FEC0FQ44140989-10A9761E-81CE-4FB4-A7A0-E7350E57492AQ44233094-81F6BC1A-8780-478E-BB2C-DF0CCD07E618Q44266718-5BF932DA-F38C-4B56-A505-8029FD85F2C4Q44334363-79510DAE-7560-4AF6-A925-7BE49F5CF266Q44340060-F95E5606-7EB1-475A-8D35-9FE1A2A0E30AQ44576600-CDD0E21B-94D8-46AD-BF95-C3E055EB23B9Q44576603-57140BEC-A1B3-4C47-A6CD-C6C724F5268FQ44633724-6653BB7B-6E03-4B5E-97D5-22FEDED7A597Q44634145-9BCFD19B-8DC5-4476-89C4-3BD728C0C5C7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Harry Scheinin
@ast
Harry Scheinin
@en
Harry Scheinin
@es
Harry Scheinin
@nl
Harry Scheinin
@sl
type
label
Harry Scheinin
@ast
Harry Scheinin
@en
Harry Scheinin
@es
Harry Scheinin
@nl
Harry Scheinin
@sl
prefLabel
Harry Scheinin
@ast
Harry Scheinin
@en
Harry Scheinin
@es
Harry Scheinin
@nl
Harry Scheinin
@sl
P106
P21
P31
P3835
harry-scheinin
P496
0000-0002-1171-3511